PhIII StudyEvaluating Giredestrant+Everolimust Compare w/Exemestane+Everolimus Pts ER+HER2-Breast Ca
Ritesh Parajuli
- OPEN TO ACCRUAL
trials found matching your search:
Displaying 6 of 271 Results
LUX-DX TRENDS Clinical Study
Dawn Lombardo
- OPEN TO ACCRUAL
PhIII TeclistamabMonother VSPomalidomide Bortezomib/Carfilzomib Dexamethasone RelapOR Refr MultiMyel
Lisa Xingguang Lee
- IRB INITIAL APPROVAL
Long Term Follow Up Patients Previously Tx w/ Mustang Bio, Inc. CAR-T Cell Investigational Products
Susan O'Brien
- OPEN TO ACCRUAL
CLASP II TR Pivotal Clinical Trial
Antonio Frangieh
- OPEN TO ACCRUAL
Ph I CA-4948 in Comb w/ Gemcitabine and Nab-Paclitaxel in Meta or UnresePancreatic Ductal Carcinoma
Farshid Dayyani
- OPEN TO ACCRUAL